Comparative efficacy and safety of tisagenlecleucel and axicabtagene ciloleucel among adults with r/r follicular lymphoma-Reference-Cited by-同舟云学术

Comparative efficacy and safety of tisagenlecleucel and axicabtagene ciloleucel among adults with r/r follicular lymphoma

Published:2024-01-05 Issue:3 Volume:65 Page:323-332
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Dickinson Michael¹,Martinez-Lopez Joaquin²^ORCID,Jousseaume Etienne³,Yang Hongbo⁴,Chai Xinglei⁴,Xiang Cheryl⁴,Wang Travis⁴,Zhang Jie⁵,Ramos Roberto⁵,Schuster Stephen J.⁶,Fowler Nathan⁷

Affiliation:

1. Peter MacCallum Cancer Centre, Royal Melbourne Hospital and the University of Melbourne, Melbourne, Australia

2. Department of Medicine, School of Medicine, Hospital Universitario 12 de Octubre, Complutense University, CNIO, Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain

3. Novartis Pharmaceuticals AG, Basel, Switzerland

4. Analysis Group Inc., Boston, MA, USA

5. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

6. Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA

7. The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2289854

Reference40 articles.

1. Kaseb HA Koshy NV. Follicular lymphoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2022 Dec 28]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538206/

2. Follicular lymphoma

3. Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

4. Follicular lymphoma: 2020 update on diagnosis and management

5. United States Food and Drug Administration. Highlights of prescribing information: KYMRIAH (tisagenlecleucel); 2017 [cited 2022 Dec 22]. Available from: https://www.fda.gov/media/107296/download

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The treatment of follicular lymphoma with CD19-directed chimeric antigen receptor T-cell therapy;Frontiers in Oncology;2024-06-05